Lichen International (LICN) Company Report

Analyst Coverage

Research analysts covering Lichen International.

Recent press releases and 8-K filings for LICN.

Lichen International Limited Shareholders Approve Share Capital Increase and Reverse Stock Split

LICN

Proxy Vote Outcomes

Lichen International Limited's shareholders approved all six proposals at an extraordinary general meeting held on December 30, 2025.
The company's authorized share capital was significantly increased from US$1,000,000.00 to US$200,000,000.00, by creating additional Series A and Series B ordinary shares.
Shareholders approved a share consolidation (reverse stock split) of Series A and Series B ordinary shares at a ratio of not less than one-for-twenty (1:20) and not more than one-for-two hundred (1:200). The exact ratio and effective date will be determined by the board of directors within eighteen months.

Jan 7, 2026, 10:00 PM

Lichen International Ltd to Hold Extraordinary General Meeting to Vote on Share Capital Increase and Reverse Stock Split

LICN

Delisting/Listing Issues

Proxy Vote Outcomes

Lichen International Limited (LICN) has called an Extraordinary General Meeting for December 30, 2025, to vote on proposals including a significant share capital increase and a reverse stock split.
The company proposes to increase its authorized share capital from US$1,000,000.00 to US$200,000,000.00.
Shareholders will vote on a Share Consolidation (reverse stock split) at a ratio between one (1)-for-twenty (20) and one (1)-for-two hundred (200), with the exact ratio to be determined by the Board within eighteen months.
The primary objective of the reverse stock split is to meet Nasdaq's minimum bid price requirement of US$1.00 per share and prevent the delisting of its Class A Ordinary Shares.
The Board of Directors unanimously recommends shareholders vote "FOR" all proposed resolutions.

Dec 11, 2025, 9:30 PM

Lichen International Limited Reports Q2 2025 Results, Announces Strategic Shift and Recent Corporate Actions

LICN

Earnings

M&A

New Projects/Investments

Lichen International Limited reported a net loss of ($9.182 million) for the six months ended June 30, 2025, compared to a net income of $0.767 million for the same period in 2024. Total revenues for the six months ended June 30, 2025, were $14.26 million, marking a 21.2% decrease from $18.10 million in the prior year period.
The company is undergoing a strategic shift from 2025, gradually transitioning towards IPO advisory services and external equity investments, while winding down its education support services.
Key corporate actions include changing its name to Lichen International Limited on February 10, 2025, implementing a one-for-two-hundred (1:200) reverse stock split on March 3, 2025, and completing the acquisition of the remaining 40% equity interest in Bondly HK for US$5,330,000 on February 26, 2025.
On September 19, 2025, the company closed a private placement, selling up to 15,500,000 Class A ordinary shares at $1.20 per share, which generated approximately $18,600,000 in gross proceeds.

Sep 19, 2025, 8:31 PM

Lichen International Limited Completes Private Placement of Class A Ordinary Shares

LICN

Lichen International Limited entered into securities purchase agreements on September 15, 2025, for the issuance and sale of 15,500,000 Class A ordinary shares.
The shares were sold at a price of $1.20 per share, resulting in a total purchase price of $18,600,000, which was paid in cash.
The company received the purchase price and issued the shares on September 19, 2025, through a private placement exempt from registration requirements.

Sep 19, 2025, 8:15 PM

Get instant answers from SEC filings, earnings calls & more